Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.

Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push

Lilly launches four-dose Zepbound KwikPen in the US. Self-pay starter price begins at $299 per month. Move aims to improve ...

Eli Lilly’s Zepbound Gets FDA OK for Multi-Dose Pen

The company said the weight-loss drug will be available at the same self-pay price in either the single-dose vial format or ...
The Lancet

Automated insulin delivery systems and improved glycaemic outcomes in type 1 diabetes: what comes next?

Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...

Lilly to launch multi-dose weight-loss drug device in US

Feb 23 (Reuters) - Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the ...